Related Experiment Videos
A study of mortality after temporal lobe epilepsy surgery
M J Hennessy1, Y Langan, R D Elwes
1Institute of Epileptology, Kings College Hospital, London, UK.
Neurology
|October 16, 1999
Summary
Temporal lobe epilepsy (TLE) surgery reduces mortality compared to chronic epilepsy. However, patients with right-sided mesial temporal sclerosis (MTS) still face elevated mortality risks post-surgery.
Area of Science:
- Neurology
- Neurosurgery
- Epileptology
Background:
- Temporal lobe epilepsy (TLE) is a common form of epilepsy, often treated with surgery.
- Long-term mortality risks in TLE patients undergoing surgery require ongoing investigation.
Purpose of the Study:
- To assess early and late mortality rates in a cohort of 305 patients following temporal lobe epilepsy surgery over two decades.
- To identify factors influencing mortality, including seizure status, pathology, and surgical side.
Main Methods:
- A retrospective analysis of 305 consecutive TLE surgery patients.
- Ascertainment of survival status, causes of death, and clinical details for deceased patients.
- Mortality analysis correlated with postoperative seizure control, operative pathology, and resection side.
Main Results:
- Overall mortality was lower than in comparable chronic epilepsy populations, with a standardized mortality ratio (SMR) of 4.5.
- Sudden unexpected death in epilepsy (SUDEP) occurred in 6 patients, with a rate of 1 per 455 person-years.
- Patients with right-sided mesial temporal sclerosis (MTS) showed significantly elevated mortality (SMR 32.0) and SUDEP rates, despite reduced seizure frequency in some.
Conclusions:
- TLE surgery effectively lowers, but does not eliminate, the excess mortality associated with chronic epilepsy.
- Right-sided MTS patients undergoing TLE surgery continue to experience high mortality, similar to medically intractable epilepsy groups.